Optimal Therapeutic Sequencing in Relapsed/Refractory CLL

Optimal Therapeutic Sequencing in Relapsed/Refractory CLL

In this on-demand webcast, experts discuss the importance of determining the most effective treatment sequence for patients with chronic lymphocytic leukemia (CLL) who have either relapsed or are refractory to initial therapies.

  • Provider:Clinical Care Options
  • Start Date: 2024-12-11 06:00:00
  • End Date: 2024-12-11 06:00:00
  • Credit Details: Pharmacy: 1.5 hours
  • Commercial Support: Source: Lilly (Any division) - Amount: 62032.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.